Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 CAD | -6.67% | -6.67% | -26.32% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Capitalization 1 | 16.35 | 6.592 | 6.378 |
Enterprise Value (EV) 1 | 15.61 | 4.532 | 10.48 |
P/E ratio | -0.09 x | -2.35 x | 25.3 x |
Yield | - | - | - |
Capitalization / Revenue | 3 x | 0.98 x | 0.69 x |
EV / Revenue | 2.86 x | 0.67 x | 1.14 x |
EV / EBITDA | -7.31 x | -2.06 x | -16.1 x |
EV / FCF | -10,268,443 x | -4,658,061 x | -1,563,720 x |
FCF Yield | -0% | -0% | -0% |
Price to Book | 50 x | 3.33 x | 1.04 x |
Nbr of stocks (in thousands) | 40,364 | 59,923 | 85,043 |
Reference price 2 | 0.4050 | 0.1100 | 0.0750 |
Announcement Date | 4/16/21 | 4/28/22 | 5/1/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales 1 | 4.26 | 5.373 | 5.456 | 6.719 | 9.228 |
EBITDA 1 | -0.009996 | 0.2196 | -2.136 | -2.196 | -0.6493 |
EBIT 1 | -0.021 | 0.2061 | -2.15 | -2.197 | -0.7513 |
Operating Margin | -0.49% | 3.84% | -39.4% | -32.69% | -8.14% |
Earnings before Tax (EBT) 1 | -0.107 | 0.106 | -11.56 | -2.229 | 0.2348 |
Net income 1 | -0.107 | 0.106 | -11.56 | -2.229 | 0.2348 |
Net margin | -2.51% | 1.97% | -211.94% | -33.17% | 2.54% |
EPS | - | - | -4.356 | -0.0467 | 0.002961 |
Free Cash Flow | - | -0.000132 | -1.52 | -0.9729 | -6.701 |
FCF margin | - | -0% | -27.87% | -14.48% | -72.61% |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 11/27/20 | 11/27/20 | 4/16/21 | 4/28/22 | 5/1/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net Debt 1 | 0.26 | 0.25 | - | - | 4.1 |
Net Cash position 1 | - | - | 0.74 | 2.06 | - |
Leverage (Debt/EBITDA) | -25.99 x | 1.154 x | - | - | -6.313 x |
Free Cash Flow | - | -0 | -1.52 | -0.97 | -6.7 |
ROE (net income / shareholders' equity) | - | -13% | 5,903% | -193% | 5.69% |
ROA (Net income/ Total Assets) | - | 20.6% | -101% | -45.3% | -5.41% |
Assets 1 | - | 0.5155 | 11.5 | 4.923 | -4.339 |
Book Value Per Share | - | - | 0.0100 | 0.0300 | 0.0700 |
Cash Flow per Share | - | - | 0.0200 | 0.0100 | 0 |
Capex 1 | 0.02 | 0 | - | - | 0.45 |
Capex / Sales | 0.45% | 0.08% | - | - | 4.85% |
Announcement Date | 11/27/20 | 11/27/20 | 4/16/21 | 4/28/22 | 5/1/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-26.32% | 4.94M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- JUMP Stock
- Financials Leveljump Healthcare Corp.